Separate samples from the primary and recurrent tumors were tested by extracting genomic DNA from slides of formalin-fixed, paraffin-embedded tumor tissue and analyzed by multiplex PCR amplification and a single nucleotide primer extension assay followed by capillary electrophoresis for signal detection of the presence or absence of the BRAF V600E mutation. Here, BRAF is linked to neoplasm.